Symposium 4: Hot topics in parenteral nutrition Rationale for using new lipid emulsions in parenteral nutrition and a review of the trials performed in adults

Proceedings of the Nutrition Society

Volumn 68, Issue 3, 2009, Pages 252-260

  Calder, Philip C ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Fatty acid; Fish oil; Sepsis; Surgery; Vegetable oils

Indexed keywords

ANTIBIOTIC AGENT; CLINOLEIC; FISH OIL; INTRALIPID; IVELIP; LCT; LINOLEIC ACID; LIPID EMULSION; LIPIDEM; LIPOFUNDIN; LIPOPLUS; LIPOVENOES; OLIVE OIL; OMEGA 6 FATTY ACID; OMEGAVEN; SMOFLIPID; SOYBEAN OIL; STRUCTOLIPID; UNCLASSIFIED DRUG; VEGETABLE OIL;

ABSENCE OF SIDE EFFECTS; BURN; CLINICAL PRACTICE; CLINICAL TRIAL; CONFERENCE PAPER; CRITICALLY ILL PATIENT; DIET SUPPLEMENTATION; DOSAGE SCHEDULE COMPARISON; FAT INTAKE; HOSPITALIZATION; HUMAN; IMMUNE DEFICIENCY; IMMUNOMODULATION; INFECTION; INFECTION PREVENTION; INJURY; INTENSIVE CARE UNIT; LENGTH OF STAY; MALNUTRITION; NONHUMAN; NUTRITIONAL VALUE; PARENTERAL NUTRITION; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; SOYBEAN; TOTAL PARENTERAL NUTRITION; ADULT; DRUG EFFECT; IMMUNITY; INFLAMMATION; METHODOLOGY; REVIEW; STANDARD;

ADULT; FAT EMULSIONS, INTRAVENOUS; FISH OILS; HUMANS; IMMUNITY; INFLAMMATION; PARENTERAL NUTRITION; PLANT OILS;

EID: 70349261950     PISSN: 00296651     EISSN: 14752719     Source Type: Journal    
DOI: 10.1017/S0029665109001268     Document Type: Conference Paper

References (57)

1. Calder PC & Burdge GC (2004) Fatty acids. In Bioactive Lipids, pp. 1-36 [A Nicolaou and G Kafatos, editors]. Bridgwater, Somerset: The Oily Press.
2. Gurr MI, Harwood JL & Frayn KN (2002) Lipid Biochemistry: An Introduction, 5th ed. Oxford: Wiley-Blackwell.
3. Sprecher H (2002) The roles of anabolic and catabolic reactions in the synthesis and recycling of polyunsaturated fatty acids. Prostaglandins Leukot Essent Fatty Acids 67, 79-83.
4. Edgren B & Wrtelind A (1963) The theoretical background of the intravenous nutrition with fat emulsions. Nutr Dieta Eur Rev Nutr Diet 13, 364-386.
5. Hallberg D, Schuberth O & Wretlind A (1966) Experimental and clinical studies with fat emulsion for intravenous nutrition. Nutr Dieta Eur Rev Nutr Diet 8, 245-281.
6. Wretlind A (1972) Complete intravenous nutrition. Theoretical and experimental background. Nutr Metab (Lond) 14, Suppl., 1-57.
7. Heyland DK, MacDonald S, Keefe L et al. (1998) Total parenteral nutrition in the critically ill patient: a metaanalysis. JAMA 280, 2013-2019.
8. Koch T & Heller AR (2005) Auswirkungen einer parenteralen ernahrung mit n-3-fettsauren auf das therapieergebnis - eine multizentrische analyse bei 661 patienten (Effects of parenteral nutrition with n-3-fatty acids on the result of therapy - a multicentre analysis with 661 patients). Akt Ernahrungs 30, 15-22.
9. Calder PC, Sherrington EJ, Askanazi J et al. (1994) Inhibition of lymphocyte proliferation in vitro by two lipid emulsions with different fatty acid compositions. Clin Nutr 13, 69-74.
10. Monson JRT, Sedman PC, Ramsden CW et al. (1988) Total parenteral nutrition adversely influences tumour-directed cellular cytotoxic responses in patients with gastrointestinal cancer. Eur J Surg Oncol 14, 435-443.
11. Battistella FD, Widergren JT, Anderson JT et al. (1997) A prospective, randomized trial of intravenous fat emulsion administration in trauma victims requiring total parenteral nutrition. J Trauma 43, 52-58.
12. Furukawa K, Yamamori H, Takagi K et al. (2002) Influences of soybean oil emulsion on stress response and cell-mediated immune function in moderately or severely stressed patients. Nutrition 18, 235-240.
13. Dionigi P, Dionigi R, Prati U et al. (1985) Effect of Intralipid1 on some immunological parameters and leukocyte functions in patients with esophageal and gastric cancer. Clin Nutr 4, 229-234.
14. Gogos CA, Kalfarentzos FE & Zoumbos NC (1990) Effect of different types of total parenteral nutrition on T-lymphocyte subpopulations and NK cells. Am J Clin Nutr 51, 119-122.
15. Sedman PC, Somers SS, Ramsden CW et al. (1991) Effects of different lipid emulsions on lymphocyte function during total parenteral nutrition. Br J Surg 78, 1396-1399.
16. Lenssen P, Bruemmer BA, Bowden RA et al. (1998) Intravenous lipid dose and incidence of bacteremia and fungemia in patients undergoing bone marrow transplantation. Am J Clin Nutr 67, 927-933.
17. Calder PC (2006) Use of fish oil in parenteral nutrition: rationale and reality. Proc Nutr Soc 65, 264-277.
18. Ulrich H, McCarthy Pastores S, Katz DP et al. (1996) Parenteral use of medium-chain triglycerides: a reappraisal. Nutrition 12, 231-238.
19. Adolph M (1999) Lipid emulsions in parenteral nutrition. Ann Nutr Metab 43, 1-13.
20. Quiles JL, Ramirez-Tortosa MC & Yaqoob P (2006) Olive Oil and Health. Wallingford, Oxon.: CABI.
21. Granato D, Blum S, Rossle C et al. (2000) Effects of parenteral lipid emulsions with different fatty acid composition on immune cell functions in vitro. JPEN J Parenter Enteral Nutr 24, 113-118.
22. Sala-Vila A, Barbosa VM & Calder PC (2007) Olive oil in parenteral nutrition. Curr Opin Clin Nutr Metab Care 10, 165-174.
23. Thomas-Gibson S, Jawhari A, Atlan P et al. (2004) Safe and efficacious prolonged use of an olive oil-based lipid emulsion (ClinOleic) in chronic intestinal failure. Clin Nutr 23, 697-703.
24. Reimund JM, Rahmi G, Escalin G et al. (2005) Efficacy and safety of an olive oil-based intravenous fat emulsion in adult patients on home parenteral nutrition. Aliment Pharmacol Ther 21, 445-454.
25. Vahedi K, Atlan P, Joly F et al. (2005) A 3-month doubleblind randomised study comparing an olive oil- with a soyabean oil-based intravenous lipid emulsion in home parenteral nutrition patients. Br J Nutr 94, 909-916.
26. Cano NJ, Saingra Y, Dupuy AM et al. (2006) Intradialytic parenteral nutrition: comparison of olive oil versus soybean oil-based lipid emulsions. Br J Nutr 95, 152-159.
27. Huschak G, Zur Nieden K, Hoell T et al. (2005) Olive oil based nutrition in multiple trauma patients: a pilot study. Intensive Care Med 31, 1202-1208.
28. Mateu-de Antonio J, Grau S, Luque S et al. (2008) Comparative effects of olive oil-based and soyabean oil-based emulsions on infection rate and leucocyte count in critically ill patients receiving parenteral nutrition. Br J Nutr 99, 846-854.
29. Garcýa-de-Lorenzo A, Denia R, Atlan P et al. (2005) Parenteral nutrition providing a restricted amount of linoleic acid in severely burned patients: a randomised double-blind study of an olive oil-based lipid emulsion v. medium/longchain triacylglycerols. Br J Nutr 94, 221-230.
30. Calder PC (2004) N-3 fatty acids and cardiovascular disease: evidence explained and mechanisms explored. Clin Sci (Lond) 107, 1-11.
31. Kris-Etherton PM, Harris WS & Appel LJ for the American Heart Association Nutrition Committee (2002) Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 106, 2747-2757.
32. Bucher HC, Hengstler P, Schindler C et al. (2002) N-3 polyunsaturated fatty acids in coronary heart disease: a metaanalysis of randomized controlled trials. Am J Med 112, 298-304. (Pubitemid 34219443)
33. Studer M, Briel M, Leimenstoll B et al. (2005) Effect of different antilipidemic agents and diets on mortality: a systematic review. Arch Intern Med 165, 725-730.
34. Wang C, Harris WS, Chung M et al. (2006) n-3 Fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review. Am J Clin Nutr 84, 5-17.
35. Calder PC (2006) N-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr 83, 1505S-1519S.
36. Tagawa H, Shimokawa H, Tagawa T et al. (1999) Long-term treatment with eicosapentaenoic acid augments both nitric oxide-mediated and non-nitric oxide-mediated endotheliumdependent forearm vasodilatation in patients with coronary artery disease. J Cardiovasc Pharmacol 33, 633-640.
37. Calder PC (2007) Immunomodulation by omega-3 fatty acids. Prostaglandins Leukot Essent Fatty Acids 77, 327-335.
38. Calder PC (2008) Danone Chair Monograph: Omega-3 Fatty Acids - The Good Oil? Brussels: Institut Danone.
39. Furst P & Kuhn KS (2000) Fish oil emulsions: what benefits can they bring? Clin Nutr 19, 7-14.
40. Adolph M (2001) Lipid emulsions in total parenteral nutrition - state of the art and future perspectives. Clin Nutr 20, Suppl. 4, 11-14.
41. Grimble R (2005) Fatty acid profile of modern lipid emulsions: scientific considerations for creating the ideal composition. Clin Nutr Suppl 1, 9-15.
42. Grimm H (2005) A balanced lipid emulsion - a new concept in parenteral nutrition. Clin Nutr Suppl 1, 25-30.
43. Morlion BJ, Torwesten E, Lessire A et al. (1996) The effect of parenteral fish oil on leukocyte membrane fatty acid composition and leukotriene- synthesizing capacity in postoperative trauma. Metabolism 45, 1208-1213.
44. Wachtler P, Konig W, Senkal M et al. (1997) Influence of a total parenteral nutrition enriched with w-3 fatty acids on leukotriene synthesis of peripheral leukocytes and systemic cytokine levels in patients with major surgery. J Trauma 42, 191-198.
45. Koller M, Senkal M, Kemen M et al. (2003) Impact of omega-3 fatty acid enriched TPN on leukotriene synthesis by leukocytes after major surgery. Clin Nutr 22, 59-64.
46. Grimm H, Mertes N, Goeters C et al. (2006) Improved fatty acid and leukotriene pattern with a novel lipid emulsion in surgical patients. Eur J Nutr 45, 55-60.
47. Weiss G, Meyer F, Matthies B et al. (2002) Immunomodulation by perioperative administration of n-3 fatty acids. Br J Nutr 87, S89-S94.
48. Schauder P, Rohn U, Schafer G et al. (2002) Impact of fish oil enriched total parenteral nutrition on DNA synthesis, cytokine release and receptor expression by lymphocytes in the postoperative period. Br J Nutr 87, S103-S110.
49. Wichmann MW, Thul P, Czarnetzki HD et al. (2007) Evaluation of clinical safety and beneficial effects of a fish oil containing lipid emulsion (Lipoplus, MLF541): data from a prospective, randomized, multicenter trial. Crit Care Med 35, 700-706.
50. Tsekos E, Reuter C, Stehle P et al. (2004) Perioperative administration of parenteral fish oil supplements in a routine clinical setting improves patient outcome after major abdominal surgery. Clin Nutr 23, 325-330.
51. Heller AR, Rossel T, Gottschlich B et al. (2004) Omega-3 fatty acids improve liver and pancreas function in postoperative cancer patients. Int J Cancer 111, 611-616.
52. Berger MM, Tappy L, Revelly JP et al. (2008) Fish oil after abdominal aorta aneurysm surgery. Eur J Clin Nutr 62, 1116-1122.
53. Mayer K, Fegbeutel C, Hattar K et al. (2003) W-3 vs. W-6 lipid emulsions exert differential influence on neutrophils in septic shock patients: impact on plasma fatty acids and lipid mediator generation. Intensive Care Med 29, 1472-1481.
54. Mayer K, Gokorsch S, Fegbeutel C et al. (2003) Parenteral nutrition with fish oil modulates cytokine response in patients with sepsis. Am J Respir Crit Care Med 167, 1321-1328.
55. Heller AR, Rossler S, Litz RJ et al. (2006) Omega-3 fatty acids improve the diagnosis-related clinical outcome. Crit Care Med 34, 972-979.
56. Wang X, Li W, Li N et al. (2008) Omega-3 fatty acidssupplemented parenteral nutrition decreases hyperinflammatory response and attenuates systemic disease sequelae in severe acute pancreatitis: a randomized and controlled study. JPEN J Parenter Enteral Nutr 32, 236-241.
57. Friesecke S, Lotze C, Kohler J et al. (2008) Fish oil supplementation in the parenteral nutrition of critically ill medical patients: a randomised controlled trial. Intensive Care Med 34, 1411-1420.